Table 2 Correlations between Asymptomatic Meibomian Gland Dysfunction and Cardiovascular Disease Risk Factors.
Crude rate of MGD, n (%) | Adjusted Odds ratio (95% CI)† | P value for trend | ||
|---|---|---|---|---|
WC (cm) | <80 | 22 (26) | 1 | |
80–88 | 35 (34) | 1.47 (0.22–2.79) | ||
≧89 | 32 (33) | 1.38 (0.70–2.71) | 0.41 | |
BMI (kg/m2) | <22.7 | 23 (24) | 1 | |
22.7–25.0 | 30 (34) | 1.46 (0.77–2.76) | ||
≧25.1 | 34 (34) | 1.52 (0.81–2.85) | 0.24 | |
Systolic BP (mmHg) | <124 | 29 (30) | 1 | |
124–138 | 23 (26) | 0.88 (0.45–1.71) | ||
≧139 | 37 (37) | 1.41 (0.74–2.69) | 0.22 | |
Diastolic BP (mmHg) | <76 | 27 (26) | 1 | |
76–84 | 28 (33) | 1.08 (0.57–2.05) | ||
≧85 | 34 (34) | 1.22 (0.64–2.30) | 0.48 | |
Fasting Glucose (mg/dL) | <87 | 24 (26) | 1 | |
87–93 | 28 (30) | 1.24 (0.64–2.37) | ||
≧94 | 37 (36) | 1.67 (0.86–3.22) | 0.27 | |
Postprandial Glucose (mg/dL) | <86 | 24 (25) | 1 | |
86–100 | 31 (33) | 1.77 (0.92–3.41) | ||
≧101 | 34 (35) | 1.86 (0.94–3.68) | 0.26 | |
Uric Acid (mg/dL) | <5.3 | 20 (21) | 1 | |
5.3–6.6 | 29 (31) | 1.62 (0.83–3.17) | ||
≧6.7 | 40 (40) | 2.40 (1.23–4.70) | 0.01 | |
Total-C (mg/dL) | <178 | 17 (19) | 1 | |
178–209 | 24 (24) | 1.47 (0.73–2.97) | ||
≧210 | 48 (49) | 4.24 (2.19–8.22) | <0.001 | |
LDL-C (mg/dL) | <99 | 10 (11) | 1 | |
99–126 | 27 (28) | 3.06 (1.38–6.76) | ||
≧127 | 52 (53) | 9.05 (4.19–19.55) | <0.001 | |
Fasting TG (mg/dL) | <96 | 18 (19) | 1 | |
96–156 | 23 (24) | 1.36 (0.68–2.74) | ||
≧157 | 48 (48) | 3.90 (2.02–7.54) | <0.001 | |
HDL-C (mg/dL) | ≧55 | 19 (21) | 1 | |
44–54 | 37 (36) | 2.02 (1.04–3.90) | ||
<44 | 33 (35) | 1.91 (0.97–3.77) | 0.04 | |
hs-CRP (mg/dL) | <0.75 | 30 (31) | 1 | |
0.75–1.65 | 28 (30) | 0.98 (0.52–1.82) | ||
≧1.70 | 31 (31) | 1.04 (0.56–1.91) | 0.98 | |
Presence of Hepatic Steatosis [n (%)]* | No | 21 (20) | 1 | |
Mild | 37 (39) | 2.15 (1.19–3.88) | ||
Moderate-to-severe | 24 (35) | 1.77 (0.92–3.44) | 0.008 | |
